Noninvasive Intratracheal Intubation to Study the Pathology and Physiology of Mouse Lung

Summary

The use of a model that mimics the condition of lung diseases in humans is critical for studying the pathophysiology and/or etiology of a particular disease and for developing therapeutic intervention. Here a noninvasive intratracheal intubation method that can directly deliver exogenous materials to mouse lungs is presented.

Abstract

The use of a model that mimics the condition of lung diseases in humans is critical for studying the pathophysiology and/or etiology of a particular disease and for developing therapeutic intervention. With the increasing availability of knockout and transgenic derivatives, together with a vast amount of genetic information, mice provide one of the best models to study the molecular mechanisms underlying the pathology and physiology of lung diseases. Inhalation, intranasal instillation, intratracheal instillation, and intratracheal intubation are the most widely used techniques by a number of investigators to administer materials of interest to mouse lungs. There are pros and cons for each technique depending on the goals of a study. Here a noninvasive intratracheal intubation method that can directly deliver exogenous materials to mouse lungs is presented. This technique was applied to administer bleomycin to mouse lungs as a model to study pulmonary fibrosis.

Introduction

Lung is an organ where many devastating diseases are commonly diagnosed. Among them, lung cancer is the second-most diagnosed cancer in both men and women, and the most common cause of cancer death. Chronic obstructive pulmonary disease, also known as emphysema and chronic bronchitis, is a very serious disease and the third leading cause of death in the United States. In 2011, it was estimated that 25.9 million Americans had asthma, including 7.1 million children under the age of 18. Asthma is the third leading cause of hospitalization among children under the age of 15 (American Lung Association, http://www.lung.org). In order to study the pathophysiology and/or etiology of these devastating diseases and their underlying mechanisms, the use of accurate models is critical in conjunction with convenient and noninvasive administration of various materials of interest to lung. Mice provide one of the best models to study the molecular mechanisms underlying the pathology and physiology of lung diseases because of the increasing availability of knockout and transgenic mice and a vast amount of available genetic information.

Various methods have been used by a number of investigators in different settings to deliver materials of interest to mouse lungs, including inhalation, intranasal instillation, intratracheal instillation, and intratracheal intubation^1-4. The latter procedure has not been routinely used because it is considered rather difficult to perform. Intratracheal intubation described herein is a noninvasive, simple, and quick method to deliver materials of interest to mouse lungs in order to study the effect of the delivered materials on gene expression patterns, pathology and/or physiology of lung⁵. This technique assures the delivery of exogenous materials to a whole lung and does not involve any survival surgery and thus will likely be approved by any institutional animal care and use committees.

Protocol

The following protocol describes a noninvasive, simple, and quick method to deliver materials of interest to mouse lungs. This procedure was approved by the National Cancer Institute Animal Care and Use Committee.

1. Anesthesia

1. First, anesthetize the mouse using a mixture of ketamine and xylazine (100 mg/kg body weight and 10 mg/kg body weight, respectively). This is the ACUC recommended anesthesia and dose. With this amount, mice are unconscious at least for ~20 min.
2. Apply vet ointment to the eyes of the mouse in order to prevent drying of the eyes during anesthesia.
3. After several minutes, pinch a foot of the mouse to check for consciousness. Once confirmed unconscious, place the mouse on an intubation stand angled at ~60° and hold it in place by hooking its upper incisors over a small rubber band located at the top of the stand.

2. Intratracheal Intubation

1. Gently retract the mouse's tongue to one side using a Q-tip.
2. When using the BioLITE Intubation Illumination System, carefully insert the intubation system until the larynx is visualized with the aid of the fiber-optic light guide.
3. Once the epiglottis and the arytenoid cartilages are visualized, insert the fiber over the epiglottis and between the arytenoid cartilages, and advance until the proper length of catheter has been inserted.

Note: In order to obtain the proper length of catheter to be inserted, initially measure the length between the mouth and the bronchial bifurcation point by using a practice mouse of a similar size in advance (Figure 1). The length largely depends on the size of the mouse. Insertion of the catheter should stop above the bifurcation point (~1.5 cm for mouse with ~25 g of body weight). This ensures that the intubated material will go to all lobes. At least 50 practice mice may be required for a person performing the intubation to become proficient in the technique (Proficient means that the success rate of intubation is more than 95%).

4. Once the catheter is inserted, quickly remove the fiber-optic light guide from the catheter to allow the animal to breathe normally. When the Intubation Illumination System is not used, directly insert a catheter as described.
5. Add a solution containing materials of interest to a catheter. Make sure that the solution is sucked into the lung immediately after addition. Fifty microliters for ~25 g mouse body weight is routinely used.

3. Animal Recovery

1. As soon as the solution is sucked into the lung, take down the mouse from the stand, and put it back into the original cage.
2. Observe the mouse until it starts moving.
3. Once confirmed that the mouse is in good condition, return the cage to a rack.

Results

Initially, green-dyed solution was used to intubate mice for practice. The lung was resected immediately after intubation to examine how evenly the color was distributed in the lung (Figure 2). This technique was applied to study bleomycin-induced pulmonary fibrosis using C57BL/6 mice. When the mice were intratracheally intubated with 1.2 U/kg of bleomycin or saline as control and necropsied 3 weeks later, the mice developed bleomycin-induced fibrosis throughout their lungs, supported by histology and th...

Discussion

Intratracheal intubation described here is a simple, yet excellent noninvasive method to evenly deliver materials of interest to mouse lung. This method allows study of the effect and/or role of the material administered on the physiology and/or pathology of lung. The materials administered can be endogenous molecules such as cytokines, or exogenous materials such as xenobiotic chemicals/drugs, carcinogens, pollutants, allergens, or viruses that result in various lung conditions that may represent a model for studying va...

Materials

Name	Company	Catalog Number	Comments
KetaVed	Vedco		Ketamine
AnaSed Injection 20 mg	LLOYD		Xylazine
BioLite Stand	Braintree Scientific	RIS100	For mice
BioLite Intubation Illumination System	Braintree Scientific	BIO MI-KIT	For mice
22 G, 1 inch i.v. catheter	Terumo	SR-OX2225CA	For mice below 30 g. Catheter is used only for the case where the Intubation Illumination System is not used.
20 G, 1 inch i.v. catheter	Terumo	SR-OX2025CA	For mice over 30 g. Catheter is used only for the case where the Intubation Illumination System is not used.